NCT03017495View on ClinicalTrials.gov

A Clinical Study to Investigate the Potential Interactions Between Food and ACT-541468 and Between ACT-541468 and Midazolam

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
Healthy Subjects
Interventions
DRUG

Midazolam

2 mg/mL oral solution

DRUG

ACT-541468

Hard gelatin capsules for oral use at a strength of 25 mg

Trial Locations (1)

24105

Investigator Site, Kiel

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT03017495 - A Clinical Study to Investigate the Potential Interactions Between Food and ACT-541468 and Between ACT-541468 and Midazolam | Biotech Hunter | Biotech Hunter